BHC - Bausch Health Companies Inc.
| 前收市價 | 8.14 |
| 開市 | 8.10 |
| 買盤 | 8.13 x 800 |
| 賣出價 | 8.14 x 900 |
| 今日波幅 | 8.07 - 8.22 |
| 52 週波幅 | 4.00 - 10.23 |
| 成交量 | |
| 平均成交量 | 3,729,679 |
| 市值 | 3.01B |
| Beta 值 (5 年，每月) | 0.97 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.97 |
| 業績公佈日 | 2023年8月07日 - 2023年8月11日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 2010年11月10日 |
| 1 年預測目標價 | 13.10 |
Insider MonkeyTop 10 Billionaire Stocks From 10 Billionaires
In this article, we will take a look at the top 10 billionaire stocks from 10 billionaires. To see more such companies, go directly to Top 5 Billionaire Stocks From 5 Billionaires. If you want to become a billionaire, do what billionaires do. This is perhaps the most truthful cliché statements that hold true irrespective […]
Insider Monkey15 Best Stocks to Buy and Hold According to Billionaire Carl Icahn
In this article, we discuss 15 best stocks to buy and hold according to billionaire Carl Icahn. If you want to see more stocks in this selection, check out 5 Best Stocks to Buy and Hold According to Billionaire Carl Icahn. Carl Icahn, recognized for his expertise in the financial market, faced another blow on […]
BenzingaWhy Bausch Health Stock Is Tumbling Today
Bausch Health Companies Inc (NYSE: BHC) reported Q1 FY23 revenues of $1.94 billion, up 1% Y/Y, up 4% organic basis, missing the consensus estimate of $1.97 billion. Revenues for Bausch Health (excl. B+L) was $1.01 billion, down 2%. Bausch + Lomb segment reported revenues were $931 million, +5%. Salix segment revenues were $496 million for Q1, compared with $464 million a year ago. Xifaxan, Relistor, and Trulance drove sales growth. The company reported an EPS loss of $(0.55), compared with $(0.1
Insider Monkey12 Best Biotech Stocks To Buy Under $20
In this piece, we will take a look at the 12 best biotechnology stocks to buy under $20. For more stocks, head on over to 5 Best Biotech Stocks To Buy Under $20. The biotechnology industry is one of the hottest sectors right now, particularly in the aftermath of the coronavirus pandemic since it was […]
Insider Monkey13 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds
In this article, we will take a look at the 13 most undervalued healthcare stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds. According to a report by T.Rowe Price, healthcare stocks can be generally divided into two […]
BenzingaWhy Bausch Health Shares Are Trading Higher Today
Bausch Health Companies Inc (NYSE: BHC) reported Q4 revenues of $2.2 billion, flat Y/Y, up 4% organic basis, above the consensus estimate of $2.14 billion. "2022 was a transformative year for Bausch Health, as we executed our strategic priorities," said Thomas Appio, CEO of Bausch Health. "Since completing the initial public offering of Bausch + Lomb last May, we have made significant progress in de-levering our balance sheet, reducing our principal debt net of unrestricted cash by $3.2 billion.
Insider Monkey15 Largest Ophthalmology Companies in the World
In this article, we will take a look at the 15 largest ophthalmology companies in the world. If you want to see more companies in this selection, go to the 5 Largest Ophthalmology Companies in the World. The ophthalmology industry encompasses the diagnosis, treatment, and prevention of eye disorders and diseases. This includes medical and […]
Insider Monkey12 Most Undervalued Pharma Stocks To Buy According To Hedge Funds
In this article, we discuss 12 most undervalued pharma stocks to buy according to hedge funds. If you want to see more stocks in this selection, check out 5 Most Undervalued Pharma Stocks To Buy According To Hedge Funds. Fitch Ratings has assigned a ‘Neutral’ outlook to the global pharmaceutical and biotech sector, indicating Fitch’s […]
BenzingaBausch Health Investors Request Blocking Eye-Care Business Spinoff, Alleging Protection From Lawsuits
More than 50 funds that own Bausch Health Companies Inc (NYSE: BHC) investors are reportedly seeking to block the eye-care business spin-off, Bausch + Lomb Corp (NYSE: BLCO). Bausch + Lomb priced its initial public offering at $18/share, falling short of expectations. The investors say improper asset shifting protects the company from securities lawsuits seeking to hold them liable for misrepresentations about its financial health. “The spin-off likely will render Bausch Health unable to pay any
Insider Monkey11 Undervalued Canadian Stocks To Buy Now
In this article we present our list of 11 Undervalued Canadian Stocks To Buy Now. Click to skip ahead and see the top 5 Undervalued Canadian Stocks To Buy Now. Gildan Activewear Inc. (NYSE:GIL), Open Text Corporation (NASDAQ:OTEX), and Bausch Health Companies Inc. (NYSE:BHC) are some of the most undervalued Canadian stocks to buy now according […]
BenzingaBausch Health Posts Q3 Profit Despite Lower Sales, Trims FY22 Outlook
Bausch Health Companies Inc (NYSE: BHC) reported Q3 revenues of $2.05 billion, down 3% Y/Y, up 2% organic basis, below the consensus estimate of $2.8 billion. "We are encouraged with the top line improvement in the third quarter, with four out of five segments delivering growth on an organic basis," Thomas Appio, CEO, said. "The results this quarter demonstrate the resilient demand for our products in the current macro environment. Adjusted net income declined to $277 million from $417 million a
Insider Monkey10 Best Guru Stocks To Buy Now
In this article, we discuss 10 best Guru stocks to buy now. If you want to see more stocks in this selection, check out 5 Best Guru Stocks To Buy Now. Guru ETF allows investors access to the best investments of some of the largest, most well-known hedge funds in the finance world. By replicating […]
Insider MonkeyCarl Icahn Stock Portfolio: Top 12 Picks
In this article, we shall discuss the top 12 picks in Carl Icahn’s stock portfolio. To skip our detailed analysis of Icahn’s history, his investment strategy, and hedge fund performance, go directly and see Carl Icahn Stock Portfolio: Top 5 Picks. Carl Icahn is an American financier and currently serves as the Chief Executive Officer […]
Insider Monkey13 Stocks to Sell Now According to Billionaire Larry Robbins
In this article, we will discuss the 13 stocks to sell now according to billionaire Larry Robbins. If you want to skip the detailed analysis of Robbins’ investment philosophy, go directly to 5 Stocks to Sell Now According to Billionaire Larry Robbins. American investor and philanthropist Larry Robbins was born in 1969. Glenview Capital Management, […]
Insider MonkeyIs it Safe to Invest in Bausch Health (BHC)?
Miller Value Partners, an investment management firm, published its “Miller Opportunity Trust Fund” second quarter 2022 investor letter – a copy of which can be downloaded here. During the second quarter of 2022, the Miller Opportunity Trust – Class I shares generated a total return of -29.45% excluding sales charges. Go over the fund’s top […]
Insider MonkeyBillionaire Carl Icahn’s Latest Portfolio: Top 10 Stock Picks
This article discusses the top 10 stock picks of Carl Icahn’s Icahn Capital LP at the end of the second quarter. If you are short on time and already know about the fund’s history and recent performance, you can skip and go directly to Billionaire Carl Icahn’s Latest Portfolio: Top 5 Stock Picks. Barring Warren […]
InvestorPlace7 Stock Price Predictions That Are Actually Worth Listening To
Generally, Wall Street stock price predictions are hardly the best source of investing ideas that have the most upside. Investors should interpret stocks that analysts claim have the most upside carefully. Often, either the analyst is too optimistic about the company’s fair value or the stock market is wrong. Investors may pick stocks with the most promising price predictions by reviewing their stock scores. As difficult as it is to make stock price predictions based on the numbers alone, someti
- InvestorPlace
BHC Stock Continues to Fall as Bausch Health Responds to Court Decision
Wall Street is still digesting the legal drama impacting embattled pharmaceutical firm Bausch Health (NYSE:BHC). The company has promised to pursue all available options regarding an unfavorable decision impacting its subsidiary Salix Pharmaceuticals’ key therapeutic, Xifaxan. A federal court’s oral order that essentially invalidates certain patent protections for the drug opens the door for generic competition, namely by Norwich Pharmaceuticals. BHC stock is down around 9% against today’s openi
Insider Monkey10 Stocks to Buy According to Francis Chou’s Chou Associates Management
In this article, we discuss 10 stocks to buy according to Francis Chou’s Chou Associates Management. If you want to skip our detailed analysis of Chou’s investment philosophy and performance, go directly to 5 Stocks to Buy According to Francis Chou’s Chou Associates Management. Francis Chou was originally an immigrant in Canada. He is now […]
Benzinga'Well-Established' Eye Health Company Bausch + Lomb Gets Outperform Rating From This Analyst
RBC Capital markets initiated coverage on Bausch + Lomb Corp (NYSE: BLCO) with an Outperform rating and a $22 price target. The analysts see B+L as a diversified ophthalmology company with strong brand equity, reaping the rewards of over $2 billion of investment since 2018 through several new product launches and expected margin improvement. The company is a well-established eye health company operating in the $50 billion vision care, surgical, and pharmaceutical markets. RBC notes that some gap
Insider Monkey10 Best Stocks to Buy for Long Term According to ValueAct Capital
In this article, we will look at the 10 best stocks to buy for the long term according to ValueAct Capital. If you want to skip reading about ValueAct Capital’s long-term strategies and the activist hedge fund’s performance, you can go directly to 5 Best Stocks to Buy for Long Term According to ValueAct Capital. […]
Insider Monkey10 Best Healthcare Stocks to Buy According to Billionaire Larry Robbins
In this article, we will discuss 10 best healthcare stocks to buy According to Larry Robbins. If you want to skip reading about Larry Robbins’ investment philosophy and his hedge fund’s returns, you can go directly to 5 Best Healthcare Stocks to Buy According to Billionaire Larry Robbins. Larry Robbins is an American investor and […]
Insider Monkey10 Best Stocks to Buy Now According to Billionaire Larry Robbins
In this article, we discuss the 10 best stocks to buy now according to billionaire Larry Robbins. You can skip our detailed analysis of Glenview Capital and go directly to 5 Best Stocks to Buy Now According to Billionaire Larry Robbins. Larry Robbins is a billionaire hedge fund manager as well as a philanthropist. He […]
The Motley FoolMarket Correction: 3 Cheap Stocks to Add to Your TFSA
Canadian investors should look to snatch up cheap stocks like Rogers Communications Inc. (TSX:RCI.B)(NYSE:RCI) in their TFSAs today. The post Market Correction: 3 Cheap Stocks to Add to Your TFSA appeared first on The Motley Fool Canada.
InvestorPlace2 Cheap Stocks Trading at “Deal of the Century” Prices
This article is excerpted from Tom Yeung’s Profit & Protection newsletter. To make sure you don’t miss any of Tom’s picks, subscribe to his mailing list here. The Market Rout Has Made Deals of the Century Let me tell you something: I hate deal hunting.InvestorPlace - Stock Market News, Stock Advice & Trading Tips No matter how long I look for a bargain, I’ll find a cheaper version the moment I’ve finished paying. Want to buy a used car? Just wait until my friend finally sells me his 2004 Bentley